Skip to content

Clinical Efficacy Observation of Acupotomy Stimulation of Femoral Nerve Branches Combined with PRP in the Treatment of Knee Osteoarthritis and Its Impact on the Degree of Articular Cartilage Damage

Clinical Efficacy Observation of Acupotomy Stimulation of Femoral Nerve Branches Combined with PRP in the Treatment of Knee Osteoarthritis and Its Impact on the Degree of Articular Cartilage Damage

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000069
Enrollment
Unknown
Registered
2026-01-13
Start date
2025-02-01
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee osteoarthritis

Interventions

Combination Therapy Group:Acupotomy + Platelet-Rich Plasma Therapy
Monotherapy Group:Platelet-Rich Plasma Therapy

Sponsors

Nanchong Central Hospital, Beijing Anzhen Hospital, Capital Medical University (Nanchong Branch)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: (1) Age: 40-75 years (inclusive), any gender. (2) Diagnostic criteria: 1) Diagnosed with unilateral or bilateral OA according to Chinese Osteoarthritis Diagnosis and Treatment Guidelines. 2) Recurrent knee pain within the past month. 3) X-ray (standing or weight-bearing position) showing joint space narrowing, subchondral bone sclerosis and/or cystic changes, osteophyte formation. 4) Age =50 years. 5) Crepitus during activity. OA diagnosis requires meeting criterion 1) + any two of criteria 2-5. (3) X-ray examination: Kellgren-Lawrence grade 1-4 at screening. For bilateral involvement, the more severe side is selected as target joint; if grades equal, the side with higher WOMAC pain score is selected. (4) WOMAC pain score: =6 points in target joint at screening.

Exclusion criteria

Exclusion criteria: (1) Patients with severe systemic diseases. (2) Comorbid rheumatoid arthritis, rheumatic arthritis, joint trauma, knee infection, or bone/joint tumors. (3) Patients with local infection within 2 weeks before admission, or history of intra-articular injections (sodium hyaluronate, chitosan, corticosteroids, etc.) or steroid use within 4 weeks.

Design outcomes

Primary

MeasureTime frame
Visual Analog Scale (VAS) for Pain;Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC);Lysholm Knee Score;Articular cartilage thickness;

Countries

China

Contacts

Public ContactFeng Fang

Nanchong Central Hospital, Beijing Anzhen Hospital, Capital Medical University (Nanchong Branch)

83468762@qq.com15196790332

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 7, 2026